Target Name: SEPTIN4-AS1
NCBI ID: G101927688
Review Report on SEPTIN4-AS1 Target / Biomarker Content of Review Report on SEPTIN4-AS1 Target / Biomarker
SEPTIN4-AS1
Other Name(s): SEPTIN4 antisense RNA 1 | SEPT4-AS1

SEPTIN4-AS1: A Potential Drug Target and Biomarker

SEPTIN4-AS1 is a non-coding RNA molecule that is expressed in various tissues and cell types in the human body. Its function is not well understood, but it is known to play a role in the regulation of cell proliferation and differentiation. SEPTIN4-AS1 has also been shown to interact with several protein molecules, including TATA- binding factor (TBP), which is a transcription factor that plays a crucial role in the regulation of gene expression.

The SEPTIN4 gene is located on chromosome 2 and encodes a protein known as SEPTIN4. SEPTIN4 is a cytoskeletal protein that is involved in the regulation of cell shape and movement. It is composed of four distinct domains: an N-terminal transmembrane domain, a coiled-coil domain, a catalytic domain, and a C-terminal TBP-interactive domain. The N-terminal transmembrane domain is responsible for the protein's ability to enter the cytoplasm, while the coiled-coil domain is responsible for the protein's stability and function. The catalytic domain is responsible for the protein's catalytic activity, while the C-terminal TBP-interactive domain is responsible for the protein's interaction with TBP.

SEPTIN4-AS1 has been shown to play a role in the regulation of cell proliferation and differentiation. It has been shown to promote the growth of various cell types, including cancer cells. In addition, SEPTIN4-AS1 has been shown to inhibit the activity of the transcription factor TBP, which is responsible for the regulation of gene expression. This suggests that SEPTIN4-AS1 may be a potential drug target for cancer treatment.

SEPTIN4-AS1 has also been shown to interact with several other protein molecules, including the transcription factor E2F1, which is involved in the regulation of gene expression and cell growth. In addition, SEPTIN4-AS1 has been shown to interact with the protein hackle, which is a protein that is involved in the regulation of DNA binding proteins. This suggests that SEPTIN4-AS1 may be a potential biomarker for the diagnosis and prognosis of various diseases.

In conclusion, SEPTIN4-AS1 is a non-coding RNA molecule that is involved in the regulation of cell proliferation and differentiation. Its function is not well understood, but it is known to play a role in the regulation of cell shape and movement. SEPTIN4-AS1 has also been shown to interact with several protein molecules, including TBP and E2F1. These interactions suggest that SEPTIN4-AS1 may be a potential drug target for cancer treatment and a potential biomarker for the diagnosis and prognosis of various diseases. Further research is needed to fully understand the function of SEPTIN4-AS1 and its potential as a drug target and biomarker.

Protein Name: SEPTIN4 Antisense RNA 1

The "SEPTIN4-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEPTIN4-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1 | SETD5 | SETD6 | SETD7 | SETD9 | SETDB1 | SETDB2 | SETMAR